
Yes. ALS is named directly in Texas law, and it has been since September 1, 2019, when House Bill 3703 added amyotrophic lateral sclerosis to the Compassionate Use Program alongside multiple sclerosis and spasticity. Since September 1, 2025, House Bill 46 has added two more doors that matter to ALS families: terminal illness and hospice or palliative care are now qualifying categories in their own right. The patient must be a permanent Texas resident, and a registered physician must determine that the potential benefit of medical cannabis is reasonable in light of the risks.
This page is written for the people who actually search this topic: patients who can still direct every decision and intend to keep doing so, and the spouses, children, and caregivers researching alongside them. It stays honest the whole way, because ALS families get enough false promises from the internet already.
The most important honesty comes first: medical marijuana does not slow ALS, does not treat the disease, and does not replace the disease-directed medications your neurology team prescribes or any other part of multidisciplinary ALS care. Where a physician may consider it is narrower: specific symptoms, for a specific patient, with the risks weighed carefully, and in ALS those risks include breathing and swallowing, which is why the review here is more cautious than for almost any other condition.
If a prescription is written, Texas does not mail anyone a medical marijuana card. The physician enters the prescription into CURT, the Compassionate Use Registry of Texas, and licensed dispensaries verify it there before dispensing. Our guide to the medical marijuana card vs prescription process in Texas explains how the Texas model works.
This guide covers eligibility, the evidence stated plainly, what HB 46 changed, how the evaluation coordinates with an ALS care team, and how to book. For the complete eligibility list, see the qualifying conditions for medical marijuana in Texas.
ALS is named directly in Texas law and has qualified since September 1, 2019 under House Bill 3703. House Bill 46 added terminal illness and hospice or palliative care as further qualifying categories in 2025.
A diagnosis alone does not guarantee a prescription. A registered physician must determine that the potential benefit is reasonable in light of the risks, and in ALS that review runs deliberately careful.
Medical cannabis does not slow ALS and does not replace disease-directed medications such as riluzole or edaravone. Never stop or change a medication without the prescribing clinician involved.
Breathing and swallowing shape everything here: sedation gets extra weight when respiratory muscles are weakening, inhaled routes deserve particular caution, and HB 46 added product forms that do not depend on swallowing.
Texas uses CURT, a prescription registry. There is no physical card, prescriptions can cover up to a 90 day supply with up to four refills, and family can handle the logistics.
Amyotrophic lateral sclerosis is a progressive disease of the motor neurons, the nerve cells that carry movement signals from the brain and spinal cord to the muscles. As those neurons degenerate, muscles weaken and waste. It often begins in one hand, arm, or leg, or in the muscles of speech and swallowing, and it spreads over time. Eventually it involves the muscles used for speaking, swallowing, and breathing.
The pace varies widely from person to person, and thinking and memory usually remain intact, which matters here: most ALS patients direct their own care from diagnosis onward, even as the body makes communication and logistics harder. Disease-directed medications exist and are managed by the neurology team, and a large part of ALS care is the multidisciplinary work of therapy, breathing support, nutrition, and symptom management that protects function and comfort.
That is the context this page lives in. The question families bring is not whether cannabis treats ALS. It is whether a legal, physician-guided option can help with specific symptoms without making the harder problems, breathing, swallowing, falls, worse.
Yes. ALS is named in the statute itself, one of the conditions House Bill 3703 added by name on September 1, 2019, under the Texas Compassionate Use Program. There is no list to check and no category to argue. The diagnosis is the named condition.
Several other doors overlap it, and the physician uses whichever fits the patient. Spasticity is separately named in the law, and stiffness and cramping are part of many ALS presentations; our spasticity guide covers that condition across its causes. Persistent pain can be evaluated under the chronic pain category added in 2025. And House Bill 46 added terminal illness and hospice or palliative care as their own categories, with our palliative care guide as the companion resource when care goals turn toward comfort.
Multiple doors do not mean multiple evaluations. One physician review covers the whole picture, and the doors simply describe the legal routes available to it.
No. ALS meets the condition requirement by name, but the outcome still depends on an individual medical evaluation, and sedation, swallowing safety, and breathing status can change the answer entirely.

Families rarely arrive with abstract questions. They arrive because something specific has become hard: nights broken by cramps, a hand that no longer cooperates, meals that take an hour and still feel unsafe, or the exhaustion of managing all of it.
Caregiver observations carry real weight, and so does the patient's own account, delivered however communication works best that week: speech, text, a letter board, or a device. The physician's job is to hear the actual burden, not to rush past it.
One safety boundary belongs here, not in fine print: new or worsening breathing difficulty, choking episodes, signs of aspiration, or a sudden change in strength are matters for the ALS care team or emergency care. They are never a cannabis conversation, and no product should ever delay that call.
The honest picture: evidence for cannabis in ALS is limited. Small studies and patient surveys have looked at symptoms such as cramps, spasticity, sleep, and appetite, with mixed and modest findings, and most of the stronger spasticity evidence comes from multiple sclerosis populations rather than ALS. Those are legitimate discussion points for a physician. They are not promised outcomes, and no one should present them as such.
One correction has to be made plainly, because the old version of this page carried it: there is no reliable evidence that cannabis slows the progression of ALS. Early laboratory findings in animal models were never confirmed in people, and telling ALS families otherwise is not optimism, it is misinformation. Disease-directed treatment belongs with your neurology team, and medications such as riluzole or edaravone stay exactly where that team put them.
The ALS Association treats cannabis as a symptom-management question to bring to the healthcare team, not a treatment for the disease, and notes the evidence is limited. We hold the same line. Products prescribed through the Texas program also differ from the preparations used in most studies, so no published result can be treated as a promise about what a Texas product will do for an individual patient.
The risks deserve more weight here than on any other page of this site. Sedation lands differently in a person whose respiratory muscles are weakening, and anything that dulls alertness, slows reactions, or relaxes the wrong muscles gets extra scrutiny. Swallowing safety shapes whether oral forms are even sensible. Falls are already a danger when strength is going. And because HB 46 added physician-directed inhalation devices to the program, one caution belongs in plain sight: with ALS breathing involvement, inhaled routes are a conversation of particular care with the physician, and often with the pulmonology side of the ALS team, before they are ever considered.
The Texas Compassionate Use Program is the state medical marijuana program. It allows registered physicians to prescribe medical cannabis, under dose-based limits (up to 10 mg THC per dose since HB 46), to qualifying Texas patients.
The program is regulated by the Texas Department of Public Safety. Prescriptions are entered into the Compassionate Use Registry of Texas, also called CURT, by a registered physician.
In Texas, the process doesn't work like a walk-in dispensary card system. Patients speak with a qualified physician first. If the physician approves the patient, the prescription is entered into CURT. Licensed dispensing organizations can then look up the prescription and fill it according to the physician's instructions.
ALS patients typically direct their own care throughout, and family members can handle scheduling, records, and dispensary logistics.
You can learn more about the full program here: Texas Compassionate Use Program
The process is usually simple for patients, but it still has to follow Texas law. The important part is physician review, not self-certification.
Start with a physician who understands TCUP, CURT, and condition-related eligibility under Texas law.
The physician reviews your diagnosis, symptoms, medical history, medications, and whether medical cannabis may be appropriate.
Approval is based on Texas law and the physician's medical judgment.
Patients don't enter themselves into the registry.
The dispensing organization verifies your prescription in CURT.
Schedule an evaluation with a physician registered through the Texas Compassionate Use Program. The physician reviews the diagnosis, symptoms, medications, and breathing and swallowing status, with family involved as the patient wishes. If medical cannabis is prescribed, the prescription is entered into CURT for verification by a licensed Texas dispensing organization.
A physician consultation can help you understand whether your ALS may qualify and what the next step looks like under Texas law.
Speak with a medical marijuana doctorReady to take the next step?Speak with a medical marijuana doctor to find out if you qualify under Texas law.
Find out if you qualifyA telemedicine evaluation can be done from home, with family participating and communication supported however the patient needs.
Texas patients complete their medical marijuana evaluation online through telemedicine. The appointment still needs to be handled by a registered physician who can review your health history and determine whether you qualify.
Patients complete their medical marijuana evaluation online through telemedicine. A registered physician still has to review the patient's condition and determine whether they qualify under the Texas Compassionate Use Program.
Costs can include your physician consultation and the cost of any medical cannabis products you purchase from a licensed Texas dispensing organization.
Texas doesn't charge a separate state medical marijuana card fee because Texas doesn't issue physical medical marijuana cards. If you're approved, your physician enters your prescription into CURT, and the dispensing organization verifies it before filling your order.
Current pricing is on our pricing page. A broader cost breakdown is in our guide to medical marijuana costs in Texas.
Texas does not charge a card or registration fee. Costs include the physician evaluation and any products from the licensed dispensing organization.
No. Texas doesn't issue physical medical marijuana cards, so there isn't a separate state card fee. If you're approved, your prescription is entered into CURT by your physician.
Approval timelines vary depending on your medical history and evaluation, but many patients are surprised by how straightforward the process can be. The consultation itself is often only one part of the process. The important step is the physician's medical review.
If our physician determines that medical marijuana is appropriate under Texas law, your prescription is entered into CURT. Licensed dispensing organizations can then verify the prescription before preparing your medication.
If there is ever a delay, it usually involves confirming medical information, correcting patient details, or ensuring the prescription appears properly within CURT rather than starting the evaluation over again.
The most important step is the physician's decision and prescription entry into CURT. Once the prescription is entered correctly, a licensed Texas dispensing organization can verify it and help you complete the next steps.
ALS establishes condition eligibility by name, but the physician must still determine that the potential benefit is reasonable in light of the risks, and in ALS that bar is applied carefully. The review needs the complete picture, because it shapes what is safe:
The diagnosis, when it was made, and which clinic or neurologist manages it
Every medication, including disease-directed ALS medications such as riluzole or edaravone
Your current breathing picture, including any breathing support you use
Your current swallowing status and any feeding tube
Falls, near-falls, and how transfers are going
How sedation might affect alertness, reactions, and fall risk for this patient
What a good outcome would honestly look like: better nights, fewer cramps, easier meals
Records that help include documentation of the diagnosis, notes from your ALS clinic or neurologist, breathing and swallowing evaluations when available, and your own notes on symptoms and sleep. Bring what you have, but do not let missing paperwork stop you from booking. You can prepare with our medical marijuana appointment checklist, and patients new to the process may find the first-time medical marijuana patient guide helpful.
ALS eligibility did not change under House Bill 46, which took effect September 1, 2025. The condition has been named since 2019. What changed is meaningful anyway: two new qualifying categories that fit where ALS care often goes, more product forms, a dose-based limit, and longer prescriptions. Smoking remains prohibited.
Options that do not depend on swallowing. Swallowing difficulty is core to ALS for many patients, and a routine built on capsules and tinctures gets fragile exactly when consistency matters most. House Bill 46 added patches, lotions, and suppositories, routes a patient or caregiver can actually administer as the disease changes. For patients who use a feeding tube, administration questions belong with the care team.
The terminal illness and palliative care categories. Both are now qualifying categories in their own right, which means the program has a path built around comfort goals, coordinated with the hospice or palliative team rather than around treatment logistics. Our palliative care guide covers that path in detail, and reading it is not giving up. It is knowing the map.
A THC limit measured by dose rather than percentage: up to 10 milligrams of THC per dose and up to 1 gram of total THC per package. In ALS, that structure supports the only responsible approach: a specific low starting amount, close observation of breathing comfort, alertness, swallowing safety, and strength, and careful adjustment or a careful stop if the trade-off is not working.
Ninety day prescriptions and access a family can manage. Prescriptions may now cover up to a 90 day supply with up to four refills, with satellite and pickup locations opening across the state. When every trip is a project involving transfers, equipment, and someone's afternoon, fewer renewals, pickup a family member can handle, and delivery where available are the difference between a plan on paper and one that works.
One caution belongs in plain sight: House Bill 46 added physician-directed inhalation devices, and with ALS breathing involvement, inhaled routes are a conversation of particular care with the physician, and often the pulmonology side of the ALS team, before they are ever considered.
ALS usually leaves the mind intact while it takes the body, which sets the rule for everything here: the patient directs the decisions, and the family makes them logistically possible. Both roles matter, and the best evaluations we see honor both.
Communication is worth planning for. If speech is affected, the evaluation works with whatever the patient uses: slowed speech, text, a letter board, a speech device, or a family member voicing while the patient confirms. The physician's questions still go to the patient, at the patient's pace.
If a prescription is written, the practical side usually lands with the family: administer exactly as directed, store the product securely, watch breathing comfort, alertness, swallowing safety, and sleep, and bring those observations to follow-ups. Whether the plan is helping is a question the household answers together, and stopping is always on the table if the trade-off is not worth it.
And through all of it, the person remains a person. The disease takes enough without the conversation talking past them.
Texas 420 Doctors has served Texas patients under the Compassionate Use Program since 2017, and ALS has been named in the law for most of that run. These are some of the most serious conversations our physicians have, and they are run accordingly: the patient's goals first, the risks stated plainly, and the whole care team respected.
Our role is not to tell an ALS family that cannabis is the answer, and we will never tell you it changes the disease, because it does not. The evaluation weighs a narrow, honest question: whether a possible improvement in cramps, sleep, appetite, or comfort is worth the real risks for this specific patient, alongside everything the ALS team is already doing. An honest no protects the patient too, and so does pointing a family to the palliative pathway when comfort is the truer goal. You can review the current team on our Meet Our Medical Marijuana Doctors in Texas page or read the statewide guide to seeing a medical marijuana doctor in Texas before scheduling.
ALS overlaps several other Texas eligibility pathways, including the named spasticity condition, the chronic pain category, and the comfort-focused categories House Bill 46 added. These related guides compare the medical issue, the eligibility pathway, and the physician evaluation process.
Prefer a physician who knows your area? Texas 420 Doctors serves patients across the state through telemedicine, with local guides for each of these major Texas cities.
Every patient is different. Reading about ALS online cannot determine whether you qualify for medical marijuana in Texas. Only a physician registered with the Texas Compassionate Use Program can review your medical history, determine whether your condition meets current eligibility requirements, and decide whether medical cannabis is an appropriate treatment option.
Medical marijuana is not intended to replace ongoing care from your neurologist, endocrinologist, oncologist, pain management specialist, primary care physician, podiatrist, or other treating clinician. Our physicians help patients understand the Texas medical marijuana process and, when appropriate, how it may fit alongside existing care.
Nothing on this page should be interpreted as individual medical advice, legal advice, or a guarantee of approval. Every recommendation is based on the physician's independent medical judgment and current Texas law.
Yes. ALS is named directly in Texas law and has qualified since September 1, 2019 under House Bill 3703. A registered physician must still review the patient and decide whether medical cannabis is appropriate, and in ALS that review runs deliberately careful.
Eligibility did not change, since ALS has been named since 2019. House Bill 46 added terminal illness and hospice or palliative care as their own qualifying categories, added product forms including patches, lotions, suppositories, and physician-directed inhalation devices, replaced the percentage THC cap with a limit of up to 10 milligrams per dose and 1 gram per package, and allowed prescriptions covering up to a 90 day supply with up to four refills. Smoking remains prohibited.
No. There is no reliable evidence that cannabis slows ALS progression, and it does not replace riluzole, edaravone, or any other treatment your neurology team prescribes. If medical cannabis is prescribed at all, it is for symptom management alongside the existing plan, never instead of it.
Those are the most common symptoms families ask about, and the honest answer is that the evidence is limited: small studies and surveys with mixed results, and most spasticity data comes from MS populations rather than ALS. They are legitimate discussion points for the physician, not promised outcomes.
Families ask about all three, and each is a reasonable conversation to bring to the evaluation. The evidence is thin, no result is promised, and the physician weighs any possible benefit against sedation, swallowing safety, and breathing status for the individual patient.
That question deserves particular caution. House Bill 46 added physician-directed inhalation devices to the program, but ALS involves progressive respiratory muscle weakness, so inhaled routes are a careful conversation with the physician, and often the pulmonology side of the care team, before they are ever considered. Other product forms exist for a reason.
House Bill 46 added forms that do not depend on swallowing, including patches, lotions, and suppositories, which matters when capsules and tinctures are no longer reliable or safe. For patients who use a feeding tube, administration questions belong with the care team, and the physician factors that into whether any form makes sense.
It gets extra weight here. Sedation lands differently in a person whose respiratory muscles are weakening, and it also raises fall risk when strength is already going. That trade-off sits at the center of the physician's review, and stopping is always on the table if it is not working.
House Bill 46 added terminal illness and hospice or palliative care as qualifying categories in their own right, so comfort-focused care now has its own path through the program. The evaluation centers on comfort goals, current medications, and coordination with the hospice or palliative team, and our palliative care guide covers that path in detail.
Yes. Family can handle scheduling, records, and dispensary logistics, including pickup or delivery arrangements, while the patient directs the decisions. Where a legal guardian exists, only a guardian documented in CURT may act for the patient during dispensing verification.
Yes. Telemedicine works with whatever communication the patient uses: slowed speech, text, a letter board, a device, or a family member voicing while the patient confirms. The physician still completes the full review, at the patient's pace.
No. Texas does not issue a physical medical marijuana card. If the patient is approved, the physician enters the prescription into CURT, the state registry that dispensaries use to verify patients, and there is no separate state registration fee.
If ALS symptoms are adding weight to a load your household already carries, speak with a physician who will review the full picture with you and your family, coordinate with the care team already in place, and give you a straight answer under the current Texas rules.